
    
      A) To determine whether biosynthesis of PGD2 is altered in response to vascular injury in
      humans

      B) Patients will be grouped base on their aspirin using status. Three groups of no aspirin
      but an alternative anti-platelet medicine, low dose (81 mg) aspirin, high dose 325 mg aspirin
      will be enrolled.
    
  